Nour El Ghazal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nour El Ghazal has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Omar M. Ghanem
Department of Surgery, Mayo Clinic, Rochester, USA
13 shared publications - Simon Laplante
Department of Surgery, Mayo Clinic, Rochester, Minnesota
8 shared publications - Joseph Klim
Division of Hematology & Oncology, Department of Internal Medicine American University of Beirut Medical Center Beirut Lebanon
5 shared publications - Noura Jawhar
Department of Surgery, Mayo Clinic, Rochester, Minnesota
5 shared publications - Tony Boutros
Department of Surgery, Mayo Clinic, Rochester, USA
3 shared publications - Wissam Ghusn
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
3 shared publications
Latest Publications
- 15 September 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5093-5108
Metabolic and Bariatric Surgery and Change in the AI-ECG–Derived Biological-Age Gap: A Longitudinal Cohort Study
- 15 September 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5093-5108
Metabolic and Bariatric Surgery and Change in the AI-ECG–Derived Biological-Age Gap: A Longitudinal Cohort Study
- 10 July 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (8) , 4388-4396
Beyond Initial Resolution: Predictors of Recurrence of Obesity-related Medical Conditions after Metabolic and Bariatric Surgery
Introduction Metabolic and bariatric surgery (MBS) provides high rates of remission of obesity-related medical conditions (ORMC). However, recurrence of previously resolved ORMC remains an important concern. There is limited data on predictors of obesity-related medical conditions recurrence (ORMCR). Methods A retrospective study was conducted of patients undergoing primary sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), or duodenal switch (DS) between 2008 and 2022. Patients with ≥ 36 months of follow-up, ≥ 20% total weight loss, and initial remission of type 2 diabetes mellitus (T2D), hypertension (HTN), hyperlipidemia (HLD), or obstructive sleep apnea (OSA) were included. ORMC resolution and recurrence were defined using prespecified criteria. Recurrent weight gain (RWG) was categorized as no RWG (≤ 20%), moderate RWG (> 20%-≤50%), and severe RWG (> 50%). Separate multivariable Cox regression models were constructed for each ORMCR outcome. Results Among 1,323 patients with remission of at least one ORMC, ORMCR occurred in 76 (16.2%) patients with T2D, 117 (21.3%) with HTN, 71 (19.0%) with HLD, and 40 (5.4%) with OSA. Severe RWG was independently associated with increased HLD recurrence. RYGB and DS were associated with lower risks of T2D and HLD recurrence compared with SG, whereas T2D and HTN recurrence were driven by insulin dependence and higher HbA1c for T2D, and greater antihypertensive medication burden and older age for HTN. White race was protective against HTN recurrence. Conclusions The metabolic benefits of MBS remained largely durable, with ORMCR driven more strongly by baseline disease severity and patient-specific factors than by RWG itself.
- 10 July 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (8) , 4388-4396
Beyond Initial Resolution: Predictors of Recurrence of Obesity-related Medical Conditions after Metabolic and Bariatric Surgery
Introduction Metabolic and bariatric surgery (MBS) provides high rates of remission of obesity-related medical conditions (ORMC). However, recurrence of previously resolved ORMC remains an important concern. There is limited data on predictors of obesity-related medical conditions recurrence (ORMCR). Methods A retrospective study was conducted of patients undergoing primary sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), or duodenal switch (DS) between 2008 and 2022. Patients with ≥ 36 months of follow-up, ≥ 20% total weight loss, and initial remission of type 2 diabetes mellitus (T2D), hypertension (HTN), hyperlipidemia (HLD), or obstructive sleep apnea (OSA) were included. ORMC resolution and recurrence were defined using prespecified criteria. Recurrent weight gain (RWG) was categorized as no RWG (≤ 20%), moderate RWG (> 20%-≤50%), and severe RWG (> 50%). Separate multivariable Cox regression models were constructed for each ORMCR outcome. Results Among 1,323 patients with remission of at least one ORMC, ORMCR occurred in 76 (16.2%) patients with T2D, 117 (21.3%) with HTN, 71 (19.0%) with HLD, and 40 (5.4%) with OSA. Severe RWG was independently associated with increased HLD recurrence. RYGB and DS were associated with lower risks of T2D and HLD recurrence compared with SG, whereas T2D and HTN recurrence were driven by insulin dependence and higher HbA1c for T2D, and greater antihypertensive medication burden and older age for HTN. White race was protective against HTN recurrence. Conclusions The metabolic benefits of MBS remained largely durable, with ORMCR driven more strongly by baseline disease severity and patient-specific factors than by RWG itself.
- 1 June 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (11) , 1195-1202
Metabolic and bariatric surgery and risk of cardiac arrhythmias and mortality in severe obesity: a multicenter real-world propensity-matched study
- 1 June 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (11) , 1195-1202
Metabolic and bariatric surgery and risk of cardiac arrhythmias and mortality in severe obesity: a multicenter real-world propensity-matched study
- 19 May 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (10) , 1110-1119
Long-term 10 to 15 year outcomes of biliopancreatic diversion with duodenal switch
- 19 May 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (10) , 1110-1119
Long-term 10 to 15 year outcomes of biliopancreatic diversion with duodenal switch
- 14 May 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (6) , 3127-3135
Marginal Ulcers After Roux-en-Y Gastric Bypass: Patterns of Care, Treatment, and Outcomes from a Tertiary Referral Center
Background Marginal ulcers (MU) represent a common and serious complication following Roux-en-Y gastric bypass (RYGB). While most MUs heal with conservative therapy, a subset requires endoscopic or surgical intervention. This study aims to characterize management trajectories and identify predictors of perforation. Methods A retrospective review was performed to identify patients who underwent RYGB between 2008 and 2023 at a tertiary referral center and were subsequently diagnosed with MU. Baseline characteristics, management strategies, and clinical outcomes were collected. MU management was categorized as medical, endoscopic, or surgical. Continuous variables were summarized using medians with interquartile ranges (IQR), and categorical variables using frequencies and percentages. Univariate testing, multivariate regression, and time-to-event analyses were used to assess predictors of MU perforation. Results Among 2106 patients, 241 patients developed MUs (incidence 11.4%). Ulcers were identified at a median of 7.1 months (IQR 3.0–16.2) following RYGB. Most patients (77.2%) resolved with medical management, while 22.8% required escalation to endoscopic (11.2%) or surgical (11.6%) intervention. The median time from MU diagnosis to surgical intervention was 12.1 months (IQR 4.9–21.2) after excluding patients who presented with perforation at the time of MU diagnosis. Ulcer perforation occurred in 24 patients and was managed with Graham patch repair or endoscopic techniques. Multivariate analysis showed that female sex (OR 0.31; 95% CI 0.11–0.85; p = 0.035) was associated with a decreased risk of perforation, while smoking resumption at 6 months postoperatively (OR 4.46; 95% CI 1.24–16.08; p 0.025) was associated with an increased risk. Univariate analysis also demonstrated that hand-sewn anastomosis was associated with significantly higher risk of MU perforation compared with linear stapling (OR 4.25, 95% CI 1.70-10.69; p = 0.002). Conclusion Although most MUs respond to medical therapy, nearly one-quarter of patients require endoscopic or surgical intervention. Resumption of smoking after surgery and male sex are independently associated with perforation. These findings support early recognition of refractory disease, risk-factor modification, and timely escalation of care.
- 14 May 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (6) , 3127-3135
Marginal Ulcers After Roux-en-Y Gastric Bypass: Patterns of Care, Treatment, and Outcomes from a Tertiary Referral Center
Background Marginal ulcers (MU) represent a common and serious complication following Roux-en-Y gastric bypass (RYGB). While most MUs heal with conservative therapy, a subset requires endoscopic or surgical intervention. This study aims to characterize management trajectories and identify predictors of perforation. Methods A retrospective review was performed to identify patients who underwent RYGB between 2008 and 2023 at a tertiary referral center and were subsequently diagnosed with MU. Baseline characteristics, management strategies, and clinical outcomes were collected. MU management was categorized as medical, endoscopic, or surgical. Continuous variables were summarized using medians with interquartile ranges (IQR), and categorical variables using frequencies and percentages. Univariate testing, multivariate regression, and time-to-event analyses were used to assess predictors of MU perforation. Results Among 2106 patients, 241 patients developed MUs (incidence 11.4%). Ulcers were identified at a median of 7.1 months (IQR 3.0–16.2) following RYGB. Most patients (77.2%) resolved with medical management, while 22.8% required escalation to endoscopic (11.2%) or surgical (11.6%) intervention. The median time from MU diagnosis to surgical intervention was 12.1 months (IQR 4.9–21.2) after excluding patients who presented with perforation at the time of MU diagnosis. Ulcer perforation occurred in 24 patients and was managed with Graham patch repair or endoscopic techniques. Multivariate analysis showed that female sex (OR 0.31; 95% CI 0.11–0.85; p = 0.035) was associated with a decreased risk of perforation, while smoking resumption at 6 months postoperatively (OR 4.46; 95% CI 1.24–16.08; p 0.025) was associated with an increased risk. Univariate analysis also demonstrated that hand-sewn anastomosis was associated with significantly higher risk of MU perforation compared with linear stapling (OR 4.25, 95% CI 1.70-10.69; p = 0.002). Conclusion Although most MUs respond to medical therapy, nearly one-quarter of patients require endoscopic or surgical intervention. Resumption of smoking after surgery and male sex are independently associated with perforation. These findings support early recognition of refractory disease, risk-factor modification, and timely escalation of care.
- Open Access
A Comprehensive Analysis of Predictors of Marginal Ulcers After Roux-en-Y Gastric Bypass: A Cohort Review of 2106 Patients
Background and Objectives: Roux-en-Y gastric bypass (RYGB) is one of the most commonly performed metabolic and bariatric surgeries worldwide. Marginal ulcers (MU) are a common complication following RYGB, yet their pathophysiology and the contributing risk factors to their development are not fully understood. Materials and Methods: This retrospective cohort study examined patients who underwent RYGB between January 2008 and December 2023, with 1 to 5 years of follow-up. Data collected included patient- and procedure-related risk factors, as well as postoperative MU events. Statistical analysis methods included the independent samples t-tests, multivariate regression, and Cox regression analyses. Results: Our final cohort included 2106 patients and was predominantly female (80.5%), with a mean age of 47.8 ± 12.1 years and body mass index (BMI) of 45.5 ± 7.5 kg/m2. MU occurred in 241 (11.4%) patients, with a mean time to occurrence of 4.5 ± 0.02 years. History of smoking (HR = 1.87, p < 0.001) and gastroesophageal reflux disease (HR = 2.36, p < 0.001) significantly increased hazard for MU, while proton pump inhibitor use (HR = 0.18, p < 0.001) was associated with reduced hazard. Aspirin exposure, regardless of dose and chronicity, did not impact MU. Conclusions: Our findings highlight the importance of preoperative assessment and counseling in patients planning to undergo RYGB. Patient-related factors should guide postoperative monitoring and prophylaxis of MU, as this remains a debated topic amongst experts.
Open AccessA Comprehensive Analysis of Predictors of Marginal Ulcers After Roux-en-Y Gastric Bypass: A Cohort Review of 2106 Patients
Background and Objectives: Roux-en-Y gastric bypass (RYGB) is one of the most commonly performed metabolic and bariatric surgeries worldwide. Marginal ulcers (MU) are a common complication following RYGB, yet their pathophysiology and the contributing risk factors to their development are not fully understood. Materials and Methods: This retrospective cohort study examined patients who underwent RYGB between January 2008 and December 2023, with 1 to 5 years of follow-up. Data collected included patient- and procedure-related risk factors, as well as postoperative MU events. Statistical analysis methods included the independent samples t-tests, multivariate regression, and Cox regression analyses. Results: Our final cohort included 2106 patients and was predominantly female (80.5%), with a mean age of 47.8 ± 12.1 years and body mass index (BMI) of 45.5 ± 7.5 kg/m2. MU occurred in 241 (11.4%) patients, with a mean time to occurrence of 4.5 ± 0.02 years. History of smoking (HR = 1.87, p < 0.001) and gastroesophageal reflux disease (HR = 2.36, p < 0.001) significantly increased hazard for MU, while proton pump inhibitor use (HR = 0.18, p < 0.001) was associated with reduced hazard. Aspirin exposure, regardless of dose and chronicity, did not impact MU. Conclusions: Our findings highlight the importance of preoperative assessment and counseling in patients planning to undergo RYGB. Patient-related factors should guide postoperative monitoring and prophylaxis of MU, as this remains a debated topic amongst experts.
- 7 February 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (5) , 489-495
The role and effects of metabolic and bariatric surgery on endometrial cancer care
- 7 February 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (5) , 489-495
The role and effects of metabolic and bariatric surgery on endometrial cancer care